Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: Implications of Eastern Cooperative Oncology Group 5592, a randomized trial (multiple letters) [1]

Journal of the National Cancer Institute

Volumn 94, Issue 13, 2002, Pages 1029-1031

  Perrone, Francesco ^a,d,e   Gallo, Ciro ^b,d   Gridelli, Cesare ^c,d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c S G MOSCATI HOSPITAL   (Italy)

^d Clinical Trials Promoting Group (CTPG)   (Italy)

^e NCI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL; PLATINUM;

ADULT; ADVANCED CANCER; AGED; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG SAFETY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT;

AGED; AGED, 80 AND OVER; AGING; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; HUMANS; LUNG NEOPLASMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037014798     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)